|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-3-18
|
|
pubmed:abstractText |
With the advent of prostate-specific antigen (PSA) screening and the increase in the number of transrectal ultrasound-guided biopsy cores, there has been a dramatic rise in the incidence of low-risk prostate cancer (LRPC). Because > 97% of men with LRPC are likely to die of something other than prostate cancer, it is critical that patients give thought to whether early curative treatment is the only option at diagnosis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1873-7560
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
831-5
|
|
pubmed:meshHeading |
pubmed-meshheading:20800964-Adult,
pubmed-meshheading:20800964-Aged,
pubmed-meshheading:20800964-Androgen Antagonists,
pubmed-meshheading:20800964-Biopsy,
pubmed-meshheading:20800964-Disease-Free Survival,
pubmed-meshheading:20800964-Florida,
pubmed-meshheading:20800964-Humans,
pubmed-meshheading:20800964-Kaplan-Meier Estimate,
pubmed-meshheading:20800964-Logistic Models,
pubmed-meshheading:20800964-Male,
pubmed-meshheading:20800964-Middle Aged,
pubmed-meshheading:20800964-Neoplasm Staging,
pubmed-meshheading:20800964-Patient Selection,
pubmed-meshheading:20800964-Predictive Value of Tests,
pubmed-meshheading:20800964-Prostate-Specific Antigen,
pubmed-meshheading:20800964-Prostatectomy,
pubmed-meshheading:20800964-Prostatic Neoplasms,
pubmed-meshheading:20800964-Quality of Life,
pubmed-meshheading:20800964-Retrospective Studies,
pubmed-meshheading:20800964-Risk Assessment,
pubmed-meshheading:20800964-Risk Factors,
pubmed-meshheading:20800964-Time Factors,
pubmed-meshheading:20800964-Treatment Outcome,
pubmed-meshheading:20800964-Watchful Waiting
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.
|
|
pubmed:affiliation |
Department of Urology, Miller School of Medicine, University of Miami, Miami, Florida, USA. msoloway@med.miami.edu
|
|
pubmed:publicationType |
Journal Article
|
